Prot# 511.70: A 24 Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 25 Milligrams 2x Daily & 50 Milligrams 1x & 2x Daily in Premenopausal Women w/ Hypoactive Sexual Desire Disorder in North America.

Project: Research project

Project Details

StatusFinished
Effective start/end date11/13/06 → 6/23/09

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (511.7)